In the lung, TNFSF14 has been associated with airway remodeling in asthma, idiopathic pulmonary fibrosis, systemic sclerosis models (13, 14), and, more recently, disease severity in COVID-19 (15, 16). Here, TNFSF14 is linked to COVID-19.